Clinical Trials Directory

Trials / Completed

CompletedNCT00354159

Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf)

Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic HF (REDUCEhf)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
442 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this clinical research study is to evaluate the safety and effectiveness of the investigational implantable hemodynamic monitor (IHM), and of the IHM in combination with an implantable cardioverter defibrillator (ICD). The investigational IHM has the ability to record and report the force with which the heart pumps blood (heart pressures). When combined with the ICD, the device has the additional ability to send a strong electrical impulse, or shock, to the heart when it detects dangerously fast heartbeats to return it to a normal rhythm. The IHM and IHM/ICD are implanted surgically just under the skin in the upper chest area. This study will also determine how doctors use the information related to heart pressures in the management of heart failure.

Conditions

Interventions

TypeNameDescription
DEVICEImplantable Hemodynamic Monitor (Chronicle® IHM), and IHM in combination with single chamber ICD (Chronicle ICD)Surgical implantation of hemodynamic device (IHM), or IHM/ICD, and intracardiac leads.

Timeline

Start date
2006-04-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2006-07-20
Last updated
2012-08-09
Results posted
2012-08-09

Locations

52 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00354159. Inclusion in this directory is not an endorsement.